Announcement Regarding Patent Infringement Lawsuit Filed Against Recomot Inc.
Medcom Inc. announced that it filed a lawsuit against Recomot Inc. on March 30, 2026, in the Tokyo District Court. The lawsuit alleges that Recomot's "moconavi" service infringes Medcom's patent (No. 7320800) and seeks an injunction against the manufacturing, sale, and use of related products, their disposal, and damages.
📋 Article Processing Timeline
- 📰 Published: April 8, 2026 at 05:00
- 🔍 Collected: April 7, 2026 at 20:30
- 🤖 AI Analyzed: April 7, 2026 at 20:58 (28 min after Collected)
Medcom Inc. (Headquarters: Koto-ku, Tokyo; Representative Director and CEO: Yasuyuki Sato; hereinafter "the Company") announces that on March 30, 2026, it filed a lawsuit with the Tokyo District Court against Recomot Inc. (hereinafter "Recomot") alleging that Recomot's "moconavi" service infringes a patent (Patent No. 7320800) held by the Company. The lawsuit seeks an injunction against the manufacturing, sale, and use of products related to the service, their disposal, and damages.
## Background to the Filing of This Lawsuit
The Company has conducted unique technology development related to shared terminals (smartphones) and their operating systems to support efficient terminal operations in medical institutions and other settings, registering and holding the results as important intellectual property.
The Company determined that Recomot's provision of the "moconavi" service highly likely infringes the Company's patent rights. We have repeatedly requested corrective action from Recomot. However, as no satisfactory response or improvement has been received to date, and with no prospect of resolution, the Company reluctantly filed this lawsuit to protect its intellectual property rights.
## Overview of the Patent in Question
* Patent Number: Patent No. 7320800
* Name of Invention: Terminal sharing device, terminal, terminal sharing method, terminal sharing program
* Content: Basic technology for safely and efficiently sharing terminals among multiple users
## Our Stance and Future Outlook
The Company continues to invest in research and development to provide solutions that meet the expectations of our users, and we position the intellectual property acquired through these efforts as a critical asset forming the core of our business activities. To ensure that our users can use our solutions with confidence, we will continue to take appropriate measures, including legal action, as necessary, against actions that infringe our intellectual property, regardless of the size of the opposing party.
Regarding the impact of this matter on the Company's business performance, we will conduct a thorough examination and promptly announce any matters that need to be disclosed.
End
## Background to the Filing of This Lawsuit
The Company has conducted unique technology development related to shared terminals (smartphones) and their operating systems to support efficient terminal operations in medical institutions and other settings, registering and holding the results as important intellectual property.
The Company determined that Recomot's provision of the "moconavi" service highly likely infringes the Company's patent rights. We have repeatedly requested corrective action from Recomot. However, as no satisfactory response or improvement has been received to date, and with no prospect of resolution, the Company reluctantly filed this lawsuit to protect its intellectual property rights.
## Overview of the Patent in Question
* Patent Number: Patent No. 7320800
* Name of Invention: Terminal sharing device, terminal, terminal sharing method, terminal sharing program
* Content: Basic technology for safely and efficiently sharing terminals among multiple users
## Our Stance and Future Outlook
The Company continues to invest in research and development to provide solutions that meet the expectations of our users, and we position the intellectual property acquired through these efforts as a critical asset forming the core of our business activities. To ensure that our users can use our solutions with confidence, we will continue to take appropriate measures, including legal action, as necessary, against actions that infringe our intellectual property, regardless of the size of the opposing party.
Regarding the impact of this matter on the Company's business performance, we will conduct a thorough examination and promptly announce any matters that need to be disclosed.
End
FAQ
Why did Medcom file a lawsuit?
Medcom determined that Recomot's "moconavi" service infringes upon its patent rights (Patent No. 7320800), and despite multiple requests for correction, no improvements were made.
What kind of technology does the infringed patent relate to?
It relates to basic technology for safely and efficiently sharing terminals among multiple users, designed to streamline terminal operations in medical institutions.
Will this lawsuit affect Medcom's business performance?
Medcom states that the impact on business performance is currently under close examination, and they will promptly announce any matters that need to be disclosed.